{
    "id": 13358,
    "fullName": "BRAF V504_R506dup",
    "impact": "duplication",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "BRAF V504_R506dup (also referred to as R506_K507insVLR) lies within the protein kinase domain (UniProt.org). V504_R506dup confers a gain of function to the Braf protein as demonstrated by stabilization of Braf homodimers and increased downstream Erk phosphorylation in cultured cells (PMID: 23817572, PMID: 30575814), and is associated with increased Erk1/2 phosphorylation in human tumor samples (PMID: 29544532).",
            "references": [
                {
                    "id": 1902,
                    "pubMedId": 23817572,
                    "title": "Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23817572"
                },
                {
                    "id": 15556,
                    "pubMedId": 30575814,
                    "title": "Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30575814"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12166,
                    "pubMedId": 29544532,
                    "title": "BRAF activating mutations involving the \u03b23-\u03b1C loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29544532"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 673,
        "geneSymbol": "BRAF",
        "terms": [
            "BRAF",
            "B-raf",
            "B-RAF1",
            "BRAF1",
            "NS7",
            "RAFB1"
        ]
    },
    "variant": "V504_R506dup",
    "createDate": "10/29/2015",
    "updateDate": "07/08/2019",
    "referenceTranscriptCoordinates": {
        "id": 109328,
        "transcript": "NM_004333",
        "gDna": "chr7:g.140777090_140777091insAAGTACCCT",
        "cDna": "c.1518_1519insGTACTTAGG",
        "protein": "p.V504_R506dupVLR",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17518,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human embryonic kidney cells overexpressing Braf V504_R506dup were resistant to Mekinist (trametinib) in culture (PMID: 30575814).",
            "molecularProfile": {
                "id": 13544,
                "profileName": "BRAF V504_R506dup"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15556,
                    "pubMedId": 30575814,
                    "title": "Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30575814"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17516,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human embryonic kidney cells overexpressing Braf V504_R506dup were resistant to Nexavar (sorafenib) in culture (PMID: 30575814).",
            "molecularProfile": {
                "id": 13544,
                "profileName": "BRAF V504_R506dup"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15556,
                    "pubMedId": 30575814,
                    "title": "Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30575814"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17517,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human embryonic kidney cells overexpressing Braf V504_R506dup were resistant to Zelboraf (vemurafenib) in culture (PMID: 30575814).",
            "molecularProfile": {
                "id": 13544,
                "profileName": "BRAF V504_R506dup"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15556,
                    "pubMedId": 30575814,
                    "title": "Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30575814"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13544,
            "profileName": "BRAF V504_R506dup",
            "profileTreatmentApproaches": [
                {
                    "id": 14541,
                    "name": "LY3009120",
                    "profileName": "BRAF V504_R506dup"
                },
                {
                    "id": 14542,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "BRAF V504_R506dup"
                },
                {
                    "id": 14539,
                    "name": "MEK1 Inhibitor",
                    "profileName": "BRAF V504_R506dup"
                },
                {
                    "id": 14540,
                    "name": "MEK2 Inhibitor",
                    "profileName": "BRAF V504_R506dup"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 109327,
            "transcript": "XM_005250045",
            "gDna": "chr7:g.140777090_140777091insAAGTACCCT",
            "cDna": "c.1518_1519insGTACTTAGG",
            "protein": "p.V504_R506dupVLR",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 109328,
            "transcript": "NM_004333",
            "gDna": "chr7:g.140777090_140777091insAAGTACCCT",
            "cDna": "c.1518_1519insGTACTTAGG",
            "protein": "p.V504_R506dupVLR",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}